BIOMARIN PHARMACEUTICAL INC vs Aardvark Therapeutics, Inc., risk disclosures compared

3topics both disclose

7only BIOMARIN PHARMACEUTICAL INC

3only Aardvark Therapeutics, Inc.

What both disclose

Topics appearing in filings from both companies, and how many filings each.

Topic	BIOMARIN PHARMACEUTICAL INC	Aardvark Therapeutics, Inc.
Ransomware	17	4
Cross Border Data Transfer	9	3
Data Residency	2	3

Only BIOMARIN PHARMACEUTICAL INC

Topic	Filings
Restatement	5
Artificial Intelligence	4
Consent Order	3
Enforcement Action	2
Internal Control	2
Material Weakness	2
Cybersecurity Incident	1

Only Aardvark Therapeutics, Inc.

Topic	Filings
Business Continuity	7
Audit Committee Oversight	2
ESG Reporting	1

What this compares

Which of the topics we track appear in each company's SEC filings, and how often. A topic appearing for one company and not the other means one wrote the phrase down and the other did not, in the filings we hold. It does not mean one faces a risk the other does not, and it is not a comparison of how well either manages anything.

Counts reflect the filings we have collected, which is a growing subset rather than a company's complete history.

BIOMARIN PHARMACEUTICAL INC · Aardvark Therapeutics, Inc. · All companies